JAMIE JONES: Open Payments
NPI 1073167763 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,379 in 51 payments from 14 companies in 2025. Trend: 2023 $1,836 · 2024 $1,749 · 2025 $1,379
Food & beverage: $1,379
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $366 |
| AstraZeneca Pharmaceuticals LP | 4 | $232 |
| Lilly USA, LLC | 14 | $213 |
| PFIZER INC. | 5 | $188 |
| Exact Sciences Corporation | 3 | $65 |
| Amgen Inc. | 4 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| HARMONY BIOSCIENCES LLC | 1 | $33 |
| ABBVIE INC. | 1 | $29 |
Products named: Wegovy, Ozempic, TEZSPIRE, ZAVZPRET, JARDIANCE, MOUNJARO, FARXIGA, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
